Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

Published on Apr 1, 2003in Ophthalmology12.079
路 DOI :10.1016/S0161-6420(02)01969-3
Paul M. Beer13
Estimated H-index: 13
(Albany Medical College)
Sources
Abstract
Abstract Purpose To describe the pharmacokinetics occurring after the direct injection of triamcinolone acetonide into the vitreous humor of humans. Design Interventional case series. Participants Five patients who received a single 4-mg intravitreal injection of triamcinolone acetonide. Methods An aqueous humor sample was obtained from 5 eyes via an anterior chamber paracentesis at days 1, 3, 10, 17, and 31 after injection. At each visit, visual acuity and intraocular pressure were measured and indirect ophthalmoscopy was performed. A fluorescein angiogram was carried out at day 10. Concentrations were determined using high performance liquid chromatography; pharmacokinetic analysis was carried out using PK Analyst, an iterative, nonlinear, weighted, least-squares regression program. Main outcome measures Intraocular concentrations of triamcinolone were measured and population pharmacokinetic parameters were calculated. Results Pharmacokinetic data followed a two-compartment model. Peak aqueous humor concentrations ranged from 2151 to 7202 ng/ml, half-lives from 76 to 635 hours, and the integral of the area under the concentration-time curve (AUC 0-t ) from 231 to 1911 ng/h per milliliter. After a single intravitreal injection of triamcinolone, the mean elimination half-life was 18.6 days in nonvitrectomized patients. The half-life in a patient who had undergone a vitrectomy was shorter at 3.2 days. Conclusions There was considerable intrasubject variation among peak concentration, AUC 0-t values, and elimination half-lives. After intravitreal injection, measurable concentrations of triamcinolone would be expected to last for approximately 3 months (93 卤 28 days) in the absence of a vitrectomy. Because triamcinolone pharmacokinetics were characterized only in elderly patients with macular edema, the results cannot be extrapolated to other patient populations.
馃摉 Papers frequently viewed together
200412.08Ophthalmology
8 Authors (Pascale Massin, ..., Alain Gaudric)
References20
Newest
#1Jost B. Jonas (Heidelberg University)H-Index: 153
#2Antje S枚fker (Heidelberg University)H-Index: 7
Abstract PURPOSE: To report the clinical outcome of a diabetic patient with macular edema treated with an intravitreal injection of crystalline cortisone. METHODS: Interventional case report. A 73-year-old patient with diabetes mellitus presented with clinically significant diffuse macular edema caused by nonproliferative diabetic retinopathy. Despite grid laser coagulation in the macular region, cystoid macular edema progressed, and within 6 months before the cortisone injection, visual acuity ...
Source
#1Richard J Antcliff (St Thomas' Hospital)H-Index: 13
#2David J. Spalton (St Thomas' Hospital)H-Index: 48
Last. John Marshall (St Thomas' Hospital)H-Index: 102
view all 6 authors...
Abstract Purpose To investigate the use of intravitreal injection of triamcinolone acetonide (TA) for the treatment of refractory uveitic cystoid macular edema (CME). Design Prospective, nonrandomized, self-controlled comparative trial. Participants Six patients with chronic CME resistant to treatment with systemic steroids, orbital floor steroids, and cyclosporine A. Three patients were followed for more than 1 year, and the other three for between 3 and 9 months. Intervention Injection of 2 mg...
Source
#1Stephanie Young (Moorfields Eye Hospital)H-Index: 10
#2Genevieve Larkin (Moorfields Eye Hospital)H-Index: 16
Last. Susan Lightman (Moorfields Eye Hospital)H-Index: 75
view all 4 authors...
Purpose: To report the safety and efficacy of intravitreal triamcinolone in the treatment of inflammatory cystoid macular oedema (CMO) in six patients who were resistant to other forms of therapy. Methods: An open-label unmasked prospective non- randomized pilot study of six patients with idiopathic uveitis and visually significant macular oedema, resistant to periocular and/or systemic corticosteroid treatment, was carried out. Baseline examination and investigations were performed, including f...
Source
#1Glenn J. Jaffe (Duke University)H-Index: 82
#2Chang Hao Yang (Duke University)H-Index: 1
Last. Paul Ashton (Tufts Medical Center)H-Index: 29
view all 6 authors...
PURPOSE. To determine the safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained drug delivery device. METHODS. Nonbiodegradable drug delivery devices containing 2 or 15 mg of a synthetic corticosteroid, fluocinolone acetonide, were constructed. The long-term in vitro release rates of these devices were determined in protein-free buffer or buffer containing 50% plasma protein. Fifteen-milligram devices were also implanted into the vitreous cavities of rabbit eyes. Intravi...
AIM To report on clinical outcome and complications of intravitreal injection of crystalline cortisone in patients undergoing pars plana vitrectomy for treatment of proliferative vitreoretinopathy. METHODS The study included all 16 patients who underwent pars plana vitrectomy for treatment of proliferative vitreoretinopathy, who received an intravitreal injection of 10鈥20 mg crystalline triamcinolone acetonide at the end of surgery, and who were operated on by the same surgeon. Most of the vehic...
Source
#1Ronald P. Danis (IU: Indiana University)H-Index: 62
#2Thomas A. CiullaH-Index: 57
Last. Alfredo PeceH-Index: 21
view all 6 authors...
Purpose: To examine the effects of intravitreal injection of 4.0 mg triamcinolone acetonide on the visual and clinical course of exudative age-related macular degeneration. Methods: A randomized clinical trial of a single injection of triamcinolone acetonide into the vitreous cavity of experimental eyes at baseline versus observation of untreated subjects was performed in 27 patients followed up for 6 months. Inclusion criteria included exudative age-related macular degeneration with subfoveal o...
Source
Purpose null To evaluate the efficacy of indocyanine green angiography (ICGA)-guided laser photocoagulation in eyes with fluorescein angiographic evidence of occult choroidal neovascularization (O-CNV) in patients with age-related macular degeneration (ARMD) with or without pigment epithelium detachment (PED). null Methods null Eighty eyes of 79 consecutive patients with O-CNV underwent laser treatment of a clearly outlined extrafoveal ICGA hyperfluorescent area, presumed to be focal CNV. Four t...
Source
#1Jagannadh K. Challa (USYD: University of Sydney)H-Index: 2
#2Mark C Gillies (USYD: University of Sydney)H-Index: 61
Last. Francis A. Billson (USYD: University of Sydney)H-Index: 24
view all 6 authors...
Purpose: To evaluate the safety and efficacy of intravitreal triamcinolone after 18 months of follow up in patients with age-related macular degeneration and subfoveal or juxtafoveal choroidal neovascularization considered unsuitable for laser photocoagulation. Methods: Thirty eyes of 28 patients, referred from general eye clinics as well as the private clinic of one of the authors to a hospital-based retinal out-patient clinic, were treated with an intravitreal injection of triamcinolone (4mg)....
Source
#1Weiguo Liu (Albany Medical College)H-Index: 12
#2Qing-Feng LiuH-Index: 4
Last. Michael H. MillerH-Index: 14
view all 9 authors...
We have used a recently described animal model to characterize the ocular pharmacokinetics of sparfloxacin in vitreous humor of uninfected albino rabbits following systemic administration and direct intraocular injection. The relationships of lipophilicity, protein binding, and molecular weight to the penetration and elimination of sparfloxacin were compared to those of ciprofloxacin, fleroxacin, and ofloxacin. To determine whether elimination was active, elimination rates following direct injec...
Source
#1A. Madu (Albert Einstein College of Medicine)H-Index: 7
#2Martin Mayers (Albert Einstein College of Medicine)H-Index: 11
Last. Michael H. MillerH-Index: 11
view all 8 authors...
Abstract The overall importance of the peak or the mean serum concentrations as predictors of ocular drug penetration is unknown. To address this fundamental question with an agent which shows promise as adjunctive therapy in the treatment of endophthalmitis, we studied the penetration of ciprofloxacin into the aqueous and vitreous humors following three different modes of systemic administration. New Zealand white rabbits received either a single bolus dose (40 mg kg -1 ), three intermittent do...
Source
Cited By474
Newest
#1Mohammed Shareef Khan (BITS: Birla Institute of Technology and Science)H-Index: 1
#2Punna Rao Ravi (BITS: Birla Institute of Technology and Science)H-Index: 13
Last. Tanaje Venkata RadhaKrishna Mullapudi (BITS: Birla Institute of Technology and Science)
view all 3 authors...
Triamcinolone acetonide (TAA) is the drug of choice in the management of ocular inflammations due to its anti-inflammatory and immuno-suppressant activity. Available marketed formulations (Triesence, Trivaris, Kenalog) are in the suspension form recommended to be administered via intravitreal injection, which has many major complications. In the present study, we have designed and evaluated Hydroxypropyl-尾-cyclodextrin (HP-尾-CD),) based conventional formulations of TAA (aqueous suspensions) with...
Source
#1Lu Gao (CSU: Central South University)
#2Xu Zhao (CSU: Central South University)
Last. Luosheng Tang (CSU: Central South University)
view all 4 authors...
BACKGROUND To evaluate the efficacy and safety of different intravitreal corticosteroids for treating diabetic macular edema (DME). METHODS Four databases were systematically searched for randomized controlled trials comparing different intravitreal corticosteroids for treating DME. The primary outcome was the change in best-corrected visual acuity (BCVA) within 6聽months after the first injection (short-term BCVA). Secondary outcomes were the change in BCVA over 1聽year (long-term BCVA) and chang...
Source
Uveitic macular edema (ME) is a frequent complication in 8.3% of uveitis patients and is a leading cause of serious visual impairment in about 40% of cases. Despite the numerous available drugs for its treatment, at least a third of patients fail to achieve satisfactory improvement in visual acuity. First-line drugs are steroids administered by various routes, but drug intolerance or ineffectiveness occur frequently, requiring the addition of other groups of therapeutic drugs. Immunomodulatory a...
Source
Abstract null null Injection of biological molecules into the intravitreous humor is of increasing interest for the treatment of posterior segment eye diseases such as age-related degenerative macular degeneration. The injection volume is limited by an increase in intraocular pressure (IOP) and 50鈥100聽碌L are typically used for most intravitreally (IVT) applied commercial products. Direct measurement of IOP is difficult and has not been studied dependent on solution properties and injection rates...
Source
#1Keiko Hashimoto (Kyoto Prefectural University of Medicine)H-Index: 3
#2Mami Kaneko (Kyoto Prefectural University of Medicine)H-Index: 6
Last. Shigeru Hirano (Kyoto Prefectural University of Medicine)H-Index: 37
view all 7 authors...
Summary null null Objectives null Local injection of glucocorticoids (GCs) into the vocal folds has been used for treating the vocal fold lesions. While the positive effects on vocal fold nodules, polyps, or scarring have been clinically reported, some concern remains around the potential adverse effects such as vocal fold atrophy, and the mechanisms remain unclear. The present study examined the histology and gene expression of locally injected GC into the vocal folds in rats. null null null Me...
Source
#1Yan Ren (Tianjin Medical University General Hospital)H-Index: 1
#2Shufang Du (Tianjin Medical University General Hospital)H-Index: 1
Last. Hua Yan (Tianjin Medical University General Hospital)H-Index: 11
view all 6 authors...
BACKGROUND We aimed to evaluate the efficacy and safety of phacoemulsification with intravitreal 3鈥塵g triamcinolone acetonide injection in preventing postoperative inflammation and complications in patients with non-infectious anterior uveitis and panuveitis complicated cataract. METHOD In this retrospective cohort study, 140 uveitic cataract patients who received phacoemulsification and intraocular lens implantation in Shanxi Eye hospital from January 2018 to January 2020 were reviewed. The IVT...
Source
#1Sherif A. Gaballa (Minia University)H-Index: 3
#2Uday B. Kompella (Anschutz Medical Campus)H-Index: 61
Last. Hamdy Abdelkader (Minia University)H-Index: 19
view all 7 authors...
Corticosteroids remain the mainstay of the treatment for various ocular conditions affecting the ocular surface, anterior and posterior segments of the eye due to their anti-inflammatory, anti-oedematous, and anti-neovascularization properties. Prednisolone, prednisolone acetate, dexamethasone, triamcinolone acetonide, fluocinolone acetonide, and loteprednol etabonate are amongst the most widely used ophthalmic corticosteroids. Corticosteroids differ in their activity and potency in the eye due ...
Source
#1Marta Silva (UM: University of Macau)H-Index: 4
#2Tangming Peng (UM: University of Macau)H-Index: 4
Last. Wenhua Zheng (UM: University of Macau)H-Index: 38
view all 6 authors...
Abstract Diabetic retinopathy is a frequent microvascular complication of diabetes and a major cause of visual impairment. In advanced stages, the abnormal neovascularization can lead to fibrosis and subsequent tractional retinal detachment and blindness. The low bioavailability of the drugs at the target site imposed by the anatomic and physiologic barriers within the eye, requires long term treatments with frequent injections that often compromise patient鈥檚 compliance and increase the risk of ...
Source
#1Tobias P H Nissen (AAU: Aalborg University)H-Index: 1
#2Henrik Vorum (AAU: Aalborg University)H-Index: 50
Last. Kristian Aasbjerg (Aarhus University Hospital)H-Index: 8
view all 3 authors...
Proliferative diabetic retinopathy and diabetic macular edema can be a potentially sightthreatening disease if not treated correctly. It is directly correlated to the duration of diabetes and how well managed the patients' diabetes is. In the last 15 years, the treatment of diabetic eye disease has taken a quantum leap in methodology due to the group of biological agents named antivascular endothelial growth factor (anti-VEGF). The introduction of the first biological agent has revolutionized th...
Source
#1Dylan E. Parsons (Stanford University)H-Index: 2
#2Soo Hyeon Lee (Stanford University)H-Index: 1
Last. Vinit B. Mahajan (Stanford University)H-Index: 35
view all 7 authors...
Ocular disorders originating in the retina can result in a partial or total loss of vision, making drug delivery to the retina of vital importance. However, effectively delivering drugs to the retina remains a challenge for ophthalmologists due to various anatomical and physicochemical barriers in the eye. This review introduces diverse administration routes and the accordant pharmacokinetic profiles of ocular drugs to aid in the development of safe and efficient drug delivery systems to the ret...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.